1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

Caris MPI, Inc.

Have updates for this profile?  Please contribute data

About
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2008

Location

Irving TX US

Primary Industry

Biotechnology

About

Founded in 2008 and based in Texas, US, Caris MPI, Inc., dba Caris Life Sciences, operates as a biotechnology company that conducts molecular oncology research for drug development through machine learning genetic sequencing. The company's platform provides clinical trial solutions to accompany the firm's drug development research.
Current Investors
OrbiMed Advisors, T Rowe Price, NexPoint Asset Management

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Healthcare IT, Oncology/Cancer Treatment, Pharmaceutical Research & Development, Medical Software
Website
www.carislifesciences.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo